|
TDG expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.28069996222047E-09 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.11220000010537E-07 |
| Normal-vs-Stage2 |
2.332100E-02 |
| Normal-vs-Stage3 |
3.798400E-04 |
| Normal-vs-Stage4 |
4.238400E-02 |
| Stage1-vs-Stage2 |
9.810600E-01 |
| Stage1-vs-Stage3 |
1.527430E-01 |
| Stage1-vs-Stage4 |
2.613200E-01 |
| Stage2-vs-Stage3 |
3.349600E-01 |
| Stage2-vs-Stage4 |
3.937000E-01 |
| Stage3-vs-Stage4 |
8.840000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.08830000356397E-08 |
| Normal-vs-AfricanAmerican |
4.41399999995262E-06 |
| Normal-vs-Asian |
1.850190E-01 |
| Caucasian-vs-AfricanAmerican |
3.514000E-01 |
| Caucasian-vs-Asian |
9.720800E-01 |
| AfricanAmerican-vs-Asian |
7.811800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.11729999591392E-08 |
| Normal-vs-Female |
1.01149999998107E-06 |
| Male-vs-Female |
3.783800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.356700E-03 |
| Normal-vs-Extreme_Weight |
2.975700E-04 |
| Normal-vs-Obese |
1.84483999999818E-05 |
| Normal-vs-Extreme_Obese |
5.692000E-02 |
| Normal_Weight-vs-Extreme_Weight |
8.773600E-01 |
| Normal_Weight-vs-Obese |
3.891200E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.811200E-01 |
| Extreme_Weight-vs-Obese |
2.360200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
9.478600E-01 |
| Obese-vs-Extreme_Obese |
5.933400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.26890000000402E-05 |
| Normal-vs-Age(41-60Yrs) |
4.72660022232674E-10 |
| Normal-vs-Age(61-80Yrs) |
1.211120E-04 |
| Normal-vs-Age(81-100Yrs) |
6.790600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.056200E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.780400E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.951900E-04 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.297700E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.464150E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.005600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
6.52489950958568E-10 |
| Normal-VS-Type2 PRCC |
4.248300E-02 |
| Normal-VS-KIRP CIMP |
4.044800E-03 |
| Normal-VS-Unclassified PRCC |
1.421870E-03 |
| Type1 PRCC-VS-Type2 PRCC |
1.639110E-03 |
| Type1 PRCC-VS-KIRP CIMP |
4.712400E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
5.202400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
4.195600E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
3.178500E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
8.791000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.157500E-03 |
| Normal-vs-N1 |
1.209660E-04 |
| Normal-vs-N2 |
2.700400E-02 |
| N0-vs-N1 |
5.121800E-03 |
| N0-vs-N2 |
7.937200E-01 |
| N1-vs-N2 |
2.621000E-01 |
|
|
